CN Bio introduces the PhysioMimix OOC Multi-Organ Microphysiological System Expands portfolio of easy-to-use, robust and reliable human-relevant in vitro models, for fast-tracked drug discovery and development System to be launched at Society of Toxicology's 2021 Virtual Annual Meeting, 12 th 26 th March 2021 CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), otherwise known as organ-on-a-chip (OOC), today announced the commercial launch of its new PhysioMimix OOC Multi-Organ MPS. The next-generation platform combines CN Bio's in vitro 3D liver model, whose phenotype and functions mimic that in vivo, with a range of other organs to more accurately recapitulate the multi-organ and systemic effects observed in humans. Demonstrating a key milestone in the Company's mission to develop the most complete human 'body-on-a-chip' in the laboratory, the PhysioMimix OOC Multi-Organ MPS will provide advanced insights into the potential effects of novel therapeutics that were previously only achievable using animal models.